Breast Neoplasms: all 12,820 studies
Page 124 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain MetastasesCompletedNCT00098605Phase 2
- FR901228 in Treating Patients With Metastatic Breast CancerCompletedNCT00098397Phase 2
- A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a TaxaneCompletedNCT00097487
- Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00097383Phase 1/2
- The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerTerminatedNCT00097344Phase 3
- Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast CancerCompletedNCT00096668Phase 2
- Sorafenib in Treating Patients With Metastatic Breast CancerCompletedNCT00096434Phase 2
- Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast CancerTerminatedNCT00096369Phase 2
- Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast CancerCompletedNCT00096343Phase 2
- Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast CancerCompletedNCT00096291Phase 2
- Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast CancerCompletedNCT00096057Phase 1
- 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast CancerTerminatedNCT00095888Phase 2
- Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive CancersTerminatedNCT00095862Phase 1/2
- Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)CompletedNCT00095706Phase 1/2
- Hypnosis in Treating Hot Flashes in Breast Cancer SurvivorsStatus unknownNCT00094133Not applicable
- Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast CancerCompletedNCT00093834Phase 1
- Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast CancerCompletedNCT00093002Phase 2
- Exercise in Women at Risk for Breast CancerCompletedNCT00092950Phase 2
- Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)CompletedNCT00092196Phase 3
- An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)CompletedNCT00092183Phase 4
- Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast CancerCompletedNCT00090974
- Vaccine Treatment for Advanced Breast CancerTerminatedNCT00090480Phase 1/2
- Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00089362Phase 1
- Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00089323Not applicable
- Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00088998Phase 2
- Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine TreatmentCompletedNCT00087958Phase 2
- A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast CancerTerminatedNCT00087620Phase 4
- Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone TherapyCompletedNCT00087399Phase 3
- Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast CancerCompletedNCT00087347
- Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast CancerCompletedNCT00086749
- GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/NeuCompletedNCT00085020Phase 1
- Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast CancerCompletedNCT00084669Not applicable
- Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast CancerCompletedNCT00084539Phase 2
- Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast CancerCompletedNCT00084396Phase 2
- Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast CancerTerminatedNCT00083993Phase 3
- Genetic and Protein Profiling in Normal and Cancerous Breast TissueCompletedNCT00083733
- Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast CancerCompletedNCT00083304Phase 3
- Study of MDX-010 in Stage IV Breast CancerCompletedNCT00083278Phase 2
- Irinotecan and Capecitabine in Treating Women With Advanced Breast CancerCompletedNCT00083148Phase 1
- Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen TherapyWithdrawnNCT00083044
- Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast CancerCompletedNCT00083031Phase 2
- Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast CancerStatus unknownNCT00083018Phase 2
- Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast CancerStatus unknownNCT00082979Phase 2
- Study of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsCompletedNCT00082654Not applicable
- Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast CancerCompletedNCT00082277Phase 4
- To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and OlderTerminatedNCT00082095Phase 3
- Acupuncture in Treating Hot Flashes in Women With Breast CancerCompletedNCT00081965Not applicable
- Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast CancerCompletedNCT00081796Phase 3
- Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)CompletedNCT00081510Phase 2
- Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast CancerCompletedNCT00081003Not applicable
- Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast CancerCompletedNCT00080860Not applicable
- Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This DiseaseActive, not recruitingNCT00080756Phase 2
- Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast CancerCompletedNCT00080743Phase 2
- Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00080665Phase 1
- Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast CancerTerminatedNCT00080626Phase 2
- Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast CancerWithdrawnNCT00080613Phase 2
- Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)CompletedNCT00080262Phase 2
- Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer PatientsCompletedNCT00080197Phase 2
- Study of Motexafin Gadolinium and Docetaxel for Advanced Solid TumorsCompletedNCT00080041Phase 1
- Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast CancerCompletedNCT00079625Phase 1
- Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast CancerStatus unknownNCT00079248Not applicable
- Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00079170Not applicable
- Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast CancerCompletedNCT00079157Phase 1
- Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast CancerCompletedNCT00079118Phase 2
- Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid TumorsCompletedNCT00078845Phase 2
- Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast CancerCompletedNCT00078832Phase 3
- Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast CancerCompletedNCT00078572Phase 3
- A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.CompletedNCT00078000Phase 2
- Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast CancerCompletedNCT00077363Phase 2
- Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for CancerStatus unknownNCT00077090Phase 2
- Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast CancerCompletedNCT00077025Phase 2
- Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast CancerTerminatedNCT00075673Phase 1
- Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast CancerWithdrawnNCT00075413Phase 2
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast CancerWithdrawnNCT00074139Phase 1
- Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous ChemotherapyCompletedNCT00074100Phase 2
- Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast CancerCompletedNCT00072865Phase 2
- Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and CapecitabineCompletedNCT00072852Phase 2
- Breast Ultrasound and Mammography in Screening Women at High Risk for Breast CancerCompletedNCT00072501Not applicable
- Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00072319Phase 2
- Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00072020Phase 3
- Vaccine Therapy in Treating Patients With Metastatic Breast CancerTerminatedNCT00071942Phase 1
- Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2CompletedNCT00071383
- Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast CancerCompletedNCT00071357
- Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast CancerStatus unknownNCT00070278Phase 3
- Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast CancerCompletedNCT00070252Phase 1/2
- Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast CancerCompletedNCT00070057Phase 1
- Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to ChemotherapyCompletedNCT00070031Phase 2
- Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast CancerCompletedNCT00068757Phase 1
- HER-2 Protein Vaccine in Treating Women With Breast CancerCompletedNCT00068614Phase 1
- Survival TRaining for ENhancing Total Health (STRENGTH)CompletedNCT00068458Phase 2
- Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast CancerCompletedNCT00068328
- 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node DissectionCompletedNCT00068263Phase 1/2
- Acupuncture for Shortness of Breath in Cancer PatientsCompletedNCT00067691Not applicable
- Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane TherapyCompletedNCT00067314Phase 2
- Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast CancerCompletedNCT00066586Not applicable
- Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination ChemotherapyStatus unknownNCT00066547Phase 1/2
- Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast CancerCompletedNCT00066443Phase 1/2
- Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast CancerCompletedNCT00066378Phase 2
- Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor TherapyCompletedNCT00066339Phase 2
- Pemetrexed as First Line Chemotherapy for Advanced Breast CancerCompletedNCT00065533Phase 2